| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ObsEva SA (SW: OBSN)
OBSN Technical Analysis
1
| As on N/A OBSN STOCK Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
OBSNSTOCK Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 25.77 | 1.34% |
| UBSG | 25.77 | 1.34% |
| NOVN | 91.11 | -0.77% |
| NOVN | 91.11 | -0.77% |
| ABBN | 45.05 | 1.65% |
| ABBN | 45.05 | 1.65% |
| ADEN | 23.14 | 11.68% |
| ADEN | 23.14 | 11.68% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| OBSN Daily Charts |
OBSN Intraday Charts |
Whats New @ Bazaartrend |
OBSN Free Analysis |
|
|
OBSN Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
OBSN Forecast May 2025
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
OBSN Weekly Forecast
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
OBSN Forecast2025
| 4th UP Forecast | |
| 3rd UP Forecast | |
| 2nd UP Forecast | |
| 1st UP Forecast | |
| 1st DOWN Forecast | |
| 2nd DOWN Forecast | |
| 3rd DOWN Forecast | |
| 4th DOWN Forecast |
ObsEva SA ( SW Switzerland Symbol : OBSN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OBSN Business Profile
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland. Address: Chemin des Aulx, 12, Geneva, Switzerland, 1228
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service